{
    "medicine_id": "cbf381fde9b86d9b9a0fe1b39b1e867a44adb2c3",
    "platform_id": "DB00116",
    "metadata": {
        "name": "24 Multivitamins Minerals 630 IU Capsule",
        "composition": "630 IU Tetrahydrofolic acid",
        "clinical_particulars": {
            "therapeutic_indications": "For nutritional supplementation also for treating dietary shortage or imbalance",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Tetrahydrofolate is the main active metabolite of dietary folate It is vital as a coenzyme in reactions involving transfers of single carbon groups Tetrahydrofolate has a role in nucleic and amino acid synthesis As nucleic and amino acid synthesis is affected by a deficiency of tetrahydrofolate actively dividing and growing cells tend to be the first affected Tetrahydrofolate is used to treat topical sprue and megaloblastic and macrocytic anemias hematologic complications resulting from a deficiency in folic acid",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fosphenytoin can be decreased when it is combined with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The therapeutic efficacy of Raltitrexed can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The serum concentration of Tetrahydrofolic acid can be decreased when it is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Phenytoin can be decreased when it is combined with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB08898",
                        "description": "The serum concentration of the active metabolites of Tetrahydrofolic acid can be reduced when Tetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Phenobarbital can be decreased when it is combined with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Primidone can be decreased when it is combined with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The therapeutic efficacy of Pyrimethamine can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The therapeutic efficacy of Dapsone can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The therapeutic efficacy of Trimethoprim can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The therapeutic efficacy of Methotrexate can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The therapeutic efficacy of Pemetrexed can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The therapeutic efficacy of Proguanil can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "The therapeutic efficacy of Trimetrexate can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB03695",
                        "description": "The therapeutic efficacy of Piritrexim can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB04655",
                        "description": "The therapeutic efficacy of Metoprine can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB06358",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The therapeutic efficacy of Pralatrexate can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB08878",
                        "description": "The therapeutic efficacy of Aminopterin can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB12769",
                        "description": "The therapeutic efficacy of Lometrexol can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB12912",
                        "description": "The therapeutic efficacy of Nolatrexed can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB13795",
                        "description": "The therapeutic efficacy of Brodimoprim can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB14763",
                        "description": "The therapeutic efficacy of Cycloguanil can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The serum concentration of Tetrahydrofolic acid can be decreased when it is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "The serum concentration of Tetrahydrofolic acid can be decreased when it is combined with Colestipol"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The serum concentration of Carbamazepine can be decreased when it is combined with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01629",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with 5 fluorouridine"
                    },
                    {
                        "drugbank-id": "DB03419",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Uracil"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Tegafur"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Tetrahydrofolic acid is combined with Doxifluridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}